Unlock instant, AI-driven research and patent intelligence for your innovation.
Formula for preventing and treating cerebral arteriosclerosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cerebral arteriosclerosis and formula, which is applied in the direction of medical formula, medical preparations containing active ingredients, and medical raw materials derived from leeches/worms, etc., can solve the problems of major side effects of the human body, so as to prevent recurrence and cure cerebral arteriosclerosis , The effect of low cost of medicinal materials
Inactive Publication Date: 2019-01-18
长沙满旺生物工程有限公司
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, there is no very effective drug for the treatment of cerebral arteriosclerosis. Patients need to take western medicine for a long time to control the condition, and adjust the condition through physical exercise and diet control, and long-term use of western medicine will cause relatively large side effects on the human body
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] The described formula for preventing and treating cerebral arteriosclerosis is characterized in that it is made from the following raw materials in parts by weight: 4 parts of leeches, 2 parts of whole scorpion, 6 parts of buffalo horn, 2 parts of gastrodia elata, 8 parts of Achyranthes sichuanensis, loofah 2 servings, 8 servings of yam, 5 servings of licorice, and 6 servings of tortoise shell.
Embodiment 2
[0025] The described formula for preventing and treating cerebral arteriosclerosis is characterized in that it is made from the following raw materials in parts by weight: 5 parts of leeches, 3 parts of whole scorpion, 5 parts of buffalo horn, 3 parts of gastrodia elata, 7 parts of Achyranthes sichuanensis, loofah 3 parts, 7 parts of yam, 5 parts of licorice, 5 parts of tortoise shell.
Embodiment 3
[0027] The described formula for preventing and treating cerebral arteriosclerosis is characterized in that it is made from the following raw materials in parts by weight: 6 parts of leeches, 4 parts of whole scorpion, 4 parts of buffalo horns, 4 parts of gastrodia elata, 6 parts of Achyranthes sichuanensis, loofah 4 servings, 6 servings of yam, 5 servings of licorice, 4 servings of tortoise shell.
[0028] The preparation method of the above-mentioned formula for preventing and treating cerebral arteriosclerosis is:
[0029] (1) Weigh above-mentioned raw materials by described weight portion: through selection, cleaning, drying, drying to moisture content≤3%;
[0030] (2) obtain the ultrafine powder of each component through ultrafine pulverization respectively;
[0031] (3) Mixing the ultra-fine powder of each component evenly, stirring it evenly, and granulating, that is, it is obtained.
[0032] Experimental effect of the present invention
[0033] Take 100 people with ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a formula for preventing and treating cerebral arteriosclerosis, characterized in that the formula is prepared from the following raw materials in parts by weight: 3-8 parts of leech, 2-5 parts of scorpion, 3-8 parts of buffalo horn, 2-5 parts of gastrodia tuber, 4-10 parts of achyranthes bidentata, 2-5 parts of luffa veneer, 4-10 parts of yam, 2-5 parts of liquorice and 3-8 parts of tortoise shell. A Chinese medicine for treat cerebral arteriosclerosis is prepared from natural Chinese-medicinal material with easy source, low cost, definite curative effect and no toxicor side effect, and can effectively cure cerebral arteriosclerosis and is difficult to relapse.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine health preservation, in particular to a formula for preventing and treating cerebral arteriosclerosis. Background technique [0002] Cerebral arteriosclerosis refers to chronic encephalopathy such as neurasthenic syndrome, arteriosclerotic dementia, pseudobulbar palsy caused by multiple brain infarction, softening, necrosis and atrophy after cerebral arteriosclerosis. Cerebral arteriosclerosis can cause transient ischemic attack (TIA), acute cerebral circulatory disturbances such as stroke, and symptoms of chronic cerebral ischemia. Since the formation process of arteriosclerosis is quite slow, arteriosclerosis does not begin to develop in old age, but progressively spreads and aggravates with age. Most patients do not necessarily have clinical symptoms, so it is often easy to ignored by people. However, with the gradual progress of cerebral arteriosclerosis, brain tissue will soften ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More